[
    {
        "molecule_name": "prior art antibodies",
        "protein_target_name": "SIRPai and SIRPa<sub>B</sub>rr",
        "binding_metric": "IC50",
        "value": "a high concentration",
        "unit": null,
        "raw_mentions": "Despite being able to bind and block both SIRPai and SIRPa<sub>B</sub>rr, SE5A5 is not capable of blocking SIRPa signalling as measured by blocking of the recruitment of SHP-1. \nSome other prior art antibodies that are able to bind both SIRPai and SIRPa<sub>B</sub>rr without binding SIRPy are not able to block CD47 binding to SIRPa and hence do not, or only at a high IC50 concentration, block SIRPa signalling as measured by blocking of the recruitment of SHP- 1."
    },
    {
        "molecule_name": "AB115-LALA, 3F9-LALA and 7H9-LALA",
        "protein_target_name": "U937 cells",
        "binding_metric": "EC50",
        "value": "> 1",
        "unit": "pg/ml",
        "raw_mentions": "Here are the extracted sentences with the required components:\n\n* The binding is indicated as an EC50 value in Table 4, with most antibodies displaying an EC50 value in the low pg/ml range.\n* AB115-LALA, 3F9-LALA and 7H9-LALA show an EC50 value that is greater than 1 pg/ml for binding to U937 cells.\n* 3F9-LALA binds to huSIRPai and huSIRPaBrr expressed on ExpiCHO-S cells with an EC50 value greater than 1 pg/ml.\n* All tested antibodies bind huSIRPBiV2, with antibody 6 having the highest KD and thus the lowest affinity, with KD values in the range of M.\n* Estimated KDS are within the tested concentration range, with values less than 1.0E11, but when < 1.0E11 is the reported KD value, the affinity could not accurately be determined because the kinetic parameters are outside the instruments specifications."
    },
    {
        "molecule_name": "3F9-LALA",
        "protein_target_name": "huSIRPai and huSIRPaBrr",
        "binding_metric": "EC50",
        "value": "> 1",
        "unit": "pg/ml",
        "raw_mentions": "Here are the extracted sentences with the required components:\n\n* The binding is indicated as an EC50 value in Table 4, with most antibodies displaying an EC50 value in the low pg/ml range.\n* AB115-LALA, 3F9-LALA and 7H9-LALA show an EC50 value that is greater than 1 pg/ml for binding to U937 cells.\n* 3F9-LALA binds to huSIRPai and huSIRPaBrr expressed on ExpiCHO-S cells with an EC50 value greater than 1 pg/ml.\n* All tested antibodies bind huSIRPBiV2, with antibody 6 having the highest KD and thus the lowest affinity, with KD values in the range of M.\n* Estimated KDS are within the tested concentration range, with values less than 1.0E11, but when < 1.0E11 is the reported KD value, the affinity could not accurately be determined because the kinetic parameters are outside the instruments specifications."
    },
    {
        "molecule_name": "antibody 6",
        "protein_target_name": "huSIRPBiV2",
        "binding_metric": "KD",
        "value": "M",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences with the required components:\n\n* The binding is indicated as an EC50 value in Table 4, with most antibodies displaying an EC50 value in the low pg/ml range.\n* AB115-LALA, 3F9-LALA and 7H9-LALA show an EC50 value that is greater than 1 pg/ml for binding to U937 cells.\n* 3F9-LALA binds to huSIRPai and huSIRPaBrr expressed on ExpiCHO-S cells with an EC50 value greater than 1 pg/ml.\n* All tested antibodies bind huSIRPBiV2, with antibody 6 having the highest KD and thus the lowest affinity, with KD values in the range of M.\n* Estimated KDS are within the tested concentration range, with values less than 1.0E11, but when < 1.0E11 is the reported KD value, the affinity could not accurately be determined because the kinetic parameters are outside the instruments specifications."
    },
    {
        "molecule_name": "anti-SIRPa antibodies",
        "protein_target_name": "SIRPa",
        "binding_metric": "EC50",
        "value": ">10",
        "unit": "mg/ml",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nTable 6. Cellular binding of anti-SIRPa antibodies to granulocytes, CD14<sup>+</sup> monocytes and CD3<sup>+</sup> T-cells in whole blood of healthy heterozygous SIRPai/SIRPa<sub>B</sub>rr donors (al/aBIT) or a homozygous SIRPai/SIRPai donor (al/al). \n>10 = EC50 > than 10 mg/ml \nEC50 values were calculated as the concentration in pg/ml that gives a response half way between bottom and top of the curve, when using a 4- parameter logistic fit. \nA summary of the EC50 values is depicted in Table 6. \nWhile most antibodies show binding to CD3<sup>+</sup> T- cells, antibody 6, AB3-LALA, 3F9-LALA, 7H9-LALA and HEFLB do not show binding to CD3<sup>+</sup> T-cells. \nThis appears to be in alignment with the disclosure in WO2018/057669 that Abl36 binds to SIRPy, but with a low KD."
    },
    {
        "molecule_name": "Abl36",
        "protein_target_name": "SIRPy",
        "binding_metric": "KD",
        "value": "low",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nTable 6. Cellular binding of anti-SIRPa antibodies to granulocytes, CD14<sup>+</sup> monocytes and CD3<sup>+</sup> T-cells in whole blood of healthy heterozygous SIRPai/SIRPa<sub>B</sub>rr donors (al/aBIT) or a homozygous SIRPai/SIRPai donor (al/al). \n>10 = EC50 > than 10 mg/ml \nEC50 values were calculated as the concentration in pg/ml that gives a response half way between bottom and top of the curve, when using a 4- parameter logistic fit. \nA summary of the EC50 values is depicted in Table 6. \nWhile most antibodies show binding to CD3<sup>+</sup> T- cells, antibody 6, AB3-LALA, 3F9-LALA, 7H9-LALA and HEFLB do not show binding to CD3<sup>+</sup> T-cells. \nThis appears to be in alignment with the disclosure in WO2018/057669 that Abl36 binds to SIRPy, but with a low KD."
    }
]